Pulmonary Hypertension: Can Exercise Testing Help?
"A New Study Reveals How Cardiopulmonary Exercise Testing Can Improve Outcomes in Pulmonary Arterial Hypertension"
Pulmonary arterial hypertension (PAH) is a serious condition that affects the arteries in your lungs, making it harder for your heart to pump blood. While there are many treatments available, managing PAH can be challenging. Doctors need ways to accurately assess how well treatments are working and predict who is at risk of getting worse.
Traditionally, doctors have relied on methods like the World Health Organization (WHO) functional class, regular check-ups, and imaging to monitor PAH. However, a recent study published in the Journal of Heart and Lung Transplantation suggests that cardiopulmonary exercise testing (CPET) could provide valuable additional information.
CPET is a non-invasive test that measures how your heart and lungs respond to exercise. It can reveal important details about your cardiovascular health that might not be apparent at rest. This article will break down the study's findings and explain how CPET can help personalize PAH treatment and improve patient outcomes.
How Exercise Testing Fits Into PH Care
Exercise testing is described as a cornerstone of pulmonary hypertension diagnosis, prognosis, and functional evaluation. Exercise assessments are incorporated into multiparametric risk scores used for therapeutic decision-making and prognostication. Cardiopulmonary exercise testing provides valuable information in suspected or confirmed pulmonary arterial hypertension and secondary pulmonary hypertension, while noninvasive and invasive testing may be selected according to the clinical question.
What is Cardiopulmonary Exercise Testing (CPET) and Why Does It Matter?
Cardiopulmonary exercise testing (CPET) goes beyond a typical stress test. It provides a comprehensive evaluation of your heart and lungs as you exercise, measuring:
- Oxygen Uptake (VO2): How efficiently your body uses oxygen.
- Carbon Dioxide Output (VCO2): How well your body eliminates carbon dioxide.
- Minute Ventilation (VE): The amount of air you breathe per minute.
- Heart Rate Response: How your heart rate changes with exertion.
- Blood Pressure Response: How your blood pressure responds to exercise.
Recent Evidence Beyond the Six-Minute Walk
A 2025 report highlights that five-year survival in pulmonary arterial hypertension remains 60–65%, depending on subtype and cohort. Another study explored using cardiopulmonary exercise testing instead of six-minute walk distance at the first reassessment after treatment initiation in pulmonary arterial hypertension. Pediatric research is also expanding: a narrative review identified 122 studies involving exercise stress testing in children with known or suspected congenital and acquired heart disease.
Why Exercise Results Can Be Difficult to Interpret
Impaired right-ventricular contractile reserve can produce ventricular-arterial uncoupling, preventing cardiac output from increasing adequately during exercise and limiting exercise capacity. An abnormal pulmonary vascular response to exercise may indicate early pulmonary vascular disease and is associated with increased mortality. Interpretation is complicated because pulmonary hypertension may be isolated within the pulmonary vasculature or occur as a complication of chronic obstructive lung disease, left-heart failure, thromboembolism, or other underlying conditions, reflected in five established PH classifications.
Matching the Test to the Question
The 6th World Symposium on Pulmonary Hypertension recommended against defining a clinical syndrome of exercise PH until further investigation better distinguishes normal from abnormal physiological features. At the same time, understanding right-ventricular function during exercise is recognized as critical to understanding right-ventricular function in PH. Available options include cardiopulmonary exercise testing, transthoracic echocardiography, cardiac MRI, right-heart catheterization, and pressure-volume analysis, which may be applied selectively for screening, diagnosis, and risk stratification.
The Future of PAH Management: Personalized Care Through CPET
While more research is always needed, this study provides compelling evidence that CPET can play a valuable role in the management of PAH. By incorporating CPET into routine follow-up, doctors can gain a more complete picture of their patients' health, personalize treatment plans, and ultimately improve long-term outcomes. If you have PAH, talk to your doctor about whether CPET is right for you. This simple test could be a powerful tool in helping you live a longer, healthier life.
Why CPET Offers a Broad View
Cardiopulmonary exercise testing is described as the gold-standard method for assessing exercise capacity. It is a noninvasive metabolic test that integrates ventilatory and cardiovascular parameters to provide a comprehensive analysis of exercise limitation. Exercise-induced pulmonary hypertension is a haemodynamic condition linked to increased morbidity and mortality across various cardiopulmonary diseases, while traditional definitions have relied on absolute cut-offs such as mean pulmonary artery pressure above 30 mmHg during exercise.
Evolving Definitions and Guidelines
Recent efforts have focused on improving pulmonary hypertension recognition, diagnosis, and management. These efforts are reflected in current guidelines. The haemodynamic definition of pulmonary hypertension has been revised, and a definition for exercise PH has also been introduced.
Connecting Testing With Daily Life
Phenotyping exercise-induced pulmonary hypertension can be difficult because symptoms may also arise from underlying cardiopulmonary disease. Invasive cardiopulmonary exercise testing captures exercise haemodynamic and cardiopulmonary data that can help expose the causes of exertional symptoms; one reported case used iCPET to diagnose exercise-induced pulmonary hypertension. Wearable-based assessment of daily-life physical activity is being studied as a way to provide information on real-world function and potentially enhance evaluation of disease progression, although the existing evidence and its quality are under review.